Trials / Conditions / CD30-Positive Diffuse Large B-Cell Lymphoma
CD30-Positive Diffuse Large B-Cell Lymphoma
3 registered clinical trials studyying CD30-Positive Diffuse Large B-Cell Lymphoma — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Anti-CD30 biAb-AATC in Patients With Relapsed/Refractory CD30 Positive Hematopoietic Malignancies NCT05544968 | Medical College of Wisconsin | Phase 1 |
| Recruiting | Constitutive IL7R (C7R) Modified Banked Allogeneic CD30.CAR EBVSTS for CD30-Positive Lymphomas NCT06176690 | Baylor College of Medicine | Phase 1 |
| Completed | Brentuximab Vedotin and Chemotherapy in CD30+ PMBL, Diffuse Large B-Cell, and Grey Zone Lymphoma Patients NCT01994850 | Abramson Cancer Center at Penn Medicine | Phase 1 / Phase 2 |